protein biomarkers
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
FDA Approves Agilent Technologies CDx for Breast Cancer Drug Verzenio
The CDx is the first FDA-approved immunohistochemistry assay to measure Ki-67 protein expression in the context of treatment with Eli Lilly's abemaciclib (Verzenio).
Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test
Premium
The firm is validating its proteomics- and machine learning-based Prophet platform and setting up US operations in anticipation of a commercial launch next year.
Relay Therapeutics Uses Protein Motion Simulation to Develop Highly Selective Precision Cancer Drugs
Premium
The company, which raised $460 million in an IPO in July, has developed a pipeline of selective agents, two of which have advanced to Phase I clinical trials.
At the AACR annual meeting, researchers shared detection rate data for multi-cancer screening tests from Grail and Thrive Earlier Detection.